Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||
net income | 15,000,000 | 612,000,000 | -1,017,000,000 | -46,000,000 | 60,000,000 | 172,000,000 | 61,000,000 | -2,609,000,000 | 27,000,000 | 27,000,000 | -8,000,000 | -24,000,000 | -2,195,000,000 | 109,000,000 | 246,000,000 | 92,000,000 | 197,000,000 | 30,000,000 | -40,000,000 | 66,564,000 | 86,231,000 | 87,366,000 | 127,211,000 | 80,378,000 | 129,807,000 | 138,869,000 | 111,214,000 | 15,500,000 | 95,717,000 | 99,148,000 | 129,416,000 | -40,155,000 | 110,261,000 | 109,795,000 | 115,764,000 | 79,917,000 | 89,777,000 | 116,734,000 | 118,603,000 | 79,167,000 | 106,448,000 | 105,374,000 | 128,258,000 | 90,135,000 | 107,416,000 | 110,285,000 | 106,707,000 |
adjustments to reconcile to net cash from operating activities | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 247,000,000 | 242,000,000 | 236,000,000 | 243,000,000 | 248,000,000 | 246,000,000 | 278,000,000 | 287,000,000 | 292,000,000 | 287,000,000 | 276,000,000 | 282,000,000 | 293,000,000 | 301,000,000 | 303,000,000 | 295,000,000 | 297,000,000 | 322,000,000 | 242,000,000 | 81,784,000 | 83,332,000 | 79,649,000 | 80,595,000 | 87,901,000 | 80,615,000 | 73,039,000 | 81,775,000 | 77,798,000 | 31,026,000 | 31,584,000 | 33,384,000 | 32,521,000 | 29,641,000 | 29,003,000 | 26,802,000 | 27,360,000 | 25,366,000 | 23,046,000 | 26,697,000 | 24,498,000 | 24,058,000 | 21,056,000 | 19,985,000 | 20,676,000 | 19,547,000 | 26,301,000 | 22,830,000 |
deferred income taxes | -50,000,000 | -102,000,000 | -61,000,000 | -176,000,000 | -51,000,000 | -68,000,000 | -9,000,000 | -310,000,000 | -32,000,000 | 1,000,000 | -28,000,000 | -15,000,000 | -44,000,000 | -113,000,000 | -65,000,000 | -88,000,000 | -11,000,000 | -51,000,000 | -86,000,000 | -30,572,000 | -29,303,000 | -10,064,000 | 2,221,000 | -24,145,000 | -7,920,000 | -14,825,000 | -12,389,000 | -1,221,000 | 6,281,000 | -4,062,000 | 18,404,000 | 62,328,000 | -4,944,000 | 5,271,000 | -3,766,000 | 6,027,000 | -8,220,000 | 12,350,000 | 4,193,000 | -91,000 | -4,757,000 | 3,959,000 | 13,932,000 | 15,854,000 | -2,732,000 | 1,982,000 | 8,246,000 |
loss on assets classified as held for sale | 33,000,000 | 32,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
losses (gains) on sale of assets | 0 | 754,000 | 1,231,000 | ||||||||||||||||||||||||||||||||||||||||||||
losses (gains) on business disposals | 30,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation | 21,000,000 | 32,000,000 | 19,000,000 | 18,000,000 | 16,000,000 | 25,000,000 | 18,000,000 | 15,000,000 | 18,000,000 | 20,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 16,000,000 | 9,000,000 | 10,000,000 | 17,000,000 | 16,000,000 | 11,000,000 | 8,621,000 | 8,195,000 | 10,358,000 | 8,624,000 | 8,056,000 | 8,126,000 | 10,696,000 | 7,604,000 | 7,360,000 | 6,868,000 | 7,553,000 | 7,620,000 | 6,418,000 | 7,256,000 | 7,074,000 | 5,819,000 | 5,116,000 | 5,697,000 | 7,844,000 | 5,930,000 | 4,805,000 | 5,495,000 | 7,473,000 | 5,387,000 | 3,021,000 | 5,593,000 | 9,339,000 | 4,695,000 |
pension contributions | -11,000,000 | -4,000,000 | -5,000,000 | -12,000,000 | -6,000,000 | -4,000,000 | -7,000,000 | -11,000,000 | -7,000,000 | -11,000,000 | -7,000,000 | -11,000,000 | -8,000,000 | -9,000,000 | -8,000,000 | -16,000,000 | -9,000,000 | -3,000,000 | -9,000,000 | -5,326,000 | -4,771,000 | -8,733,000 | -5,397,000 | -7,324,000 | -5,709,000 | -6,725,000 | -3,956,000 | -6,450,000 | -6,020,000 | -5,576,000 | -4,387,000 | -2,428,000 | -5,313,000 | -6,294,000 | -25,263,000 | -1,991,000 | -4,846,000 | -32,100,000 | -7,410,000 | -6,772,000 | -3,632,000 | -3,445,000 | -54,048,000 | ||||
gain on extinguishment of debt | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
impairment of goodwill | 0 | 0 | 1,153,000,000 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
trade receivables | -89,000,000 | 10,000,000 | -116,000,000 | 59,000,000 | 17,000,000 | -3,000,000 | -290,000,000 | 129,000,000 | -8,000,000 | -7,000,000 | -63,000,000 | 192,000,000 | 54,000,000 | -91,000,000 | -272,000,000 | 45,000,000 | -9,000,000 | -30,000,000 | -175,000,000 | 33,313,000 | 38,146,000 | 853,000 | -133,291,000 | 82,433,000 | 64,233,000 | -31,176,000 | -55,935,000 | 43,240,000 | 6,765,000 | -38,662,000 | -61,301,000 | 26,094,000 | -17,365,000 | -16,722,000 | -60,858,000 | 14,526,000 | 34,291,000 | -9,706,000 | -60,655,000 | 16,851,000 | -16,234,000 | -29,438,000 | -62,891,000 | 45,294,000 | 2,307,000 | -8,667,000 | -41,569,000 |
inventories | -5,000,000 | -32,000,000 | -92,000,000 | -31,000,000 | -7,000,000 | -30,000,000 | 34,000,000 | 116,000,000 | 156,000,000 | 114,000,000 | 219,000,000 | -85,000,000 | -235,000,000 | -262,000,000 | -311,000,000 | -133,000,000 | -100,000,000 | -248,000,000 | 118,000,000 | 60,695,000 | 24,477,000 | -66,680,000 | -568,000 | 22,011,000 | -12,595,000 | -46,826,000 | -24,719,000 | -24,936,000 | -24,765,000 | -37,755,000 | -30,185,000 | -25,122,000 | 10,439,000 | -4,119,000 | -109,000 | 15,612,000 | 7,111,000 | -10,527,000 | 3,256,000 | -5,973,000 | -21,821,000 | -23,006,000 | 13,172,000 | -18,433,000 | -23,459,000 | 2,441,000 | -591,000 |
accounts payable | -49,000,000 | -77,000,000 | 154,000,000 | 74,000,000 | -88,000,000 | -29,000,000 | 83,000,000 | 201,000,000 | -148,000,000 | 52,000,000 | -144,000,000 | -168,000,000 | -32,000,000 | -35,000,000 | 178,000,000 | 163,000,000 | 6,000,000 | 0 | 250,000,000 | 6,330,000 | -40,672,000 | 93,900,000 | -31,635,000 | 94,796,000 | -31,687,000 | -16,633,000 | 8,988,000 | 72,334,000 | -10,059,000 | 1,296,000 | -8,435,000 | 49,674,000 | 2,919,000 | -21,501,000 | -1,978,000 | 21,881,000 | -356,000 | 208,000 | -29,375,000 | 34,791,000 | 26,047,000 | 31,496,000 | -3,061,000 | 15,343,000 | 23,241,000 | -18,842,000 | -11,989,000 |
accruals for incentive compensation | 50,000,000 | 42,000,000 | -246,000,000 | 71,000,000 | 101,000,000 | 64,000,000 | -46,000,000 | 38,000,000 | 37,000,000 | -7,000,000 | -70,000,000 | 22,000,000 | 6,000,000 | 39,000,000 | -101,000,000 | 53,000,000 | 36,000,000 | 29,000,000 | -22,000,000 | 25,118,000 | 11,546,000 | 26,827,000 | -19,340,000 | -1,631,000 | 8,612,000 | 7,631,000 | -36,969,000 | 8,464,000 | 14,405,000 | 11,425,000 | -36,583,000 | 16,237,000 | 15,223,000 | 11,169,000 | -23,485,000 | 9,121,000 | 5,013,000 | 9,597,000 | -11,598,000 | -3,618,000 | 7,410,000 | 6,484,000 | -27,675,000 | 14,535,000 | 9,488,000 | 7,312,000 | -62,282,000 |
other assets/liabilities | -103,000,000 | -76,000,000 | 102,000,000 | 73,000,000 | -118,000,000 | -56,000,000 | 7,000,000 | -72,000,000 | 24,000,000 | -83,000,000 | -18,000,000 | 111,000,000 | -67,000,000 | -63,000,000 | -22,000,000 | -20,000,000 | -48,000,000 | -25,769,000 | 967,000 | -8,663,000 | 14,969,000 | -21,881,000 | |||||||||||||||||||||||||
net cash from operating activities | 164,000,000 | 241,000,000 | 127,000,000 | 368,000,000 | 366,000,000 | 237,000,000 | 99,000,000 | 644,000,000 | 420,000,000 | 248,000,000 | 127,000,000 | 208,000,000 | 289,000,000 | -96,000,000 | -4,000,000 | 311,000,000 | 428,000,000 | 340,000,000 | 358,000,000 | 299,070,000 | 206,632,000 | 191,451,000 | 16,945,000 | 315,930,000 | 198,119,000 | 137,684,000 | 47,232,000 | 235,617,000 | 146,789,000 | 66,564,000 | -11,395,000 | 191,267,000 | 141,568,000 | 36,220,000 | 21,701,000 | 206,053,000 | 174,803,000 | 122,935,000 | 31,615,000 | 138,883,000 | 128,377,000 | 134,842,000 | 31,476,000 | 200,887,000 | 163,473,000 | 119,037,000 | 34,993,000 |
capex | -132,000,000 | -95,000,000 | -179,000,000 | -160,000,000 | -103,000,000 | -82,000,000 | -118,000,000 | -113,000,000 | -100,000,000 | -115,000,000 | -175,000,000 | -160,000,000 | -108,000,000 | -104,000,000 | -132,000,000 | -151,000,000 | -77,000,000 | -72,000,000 | -93,000,000 | -67,724,000 | -44,037,000 | -31,739,000 | -48,294,000 | -75,529,000 | -41,355,000 | -61,485,000 | -57,609,000 | -67,673,000 | -35,000,000 | -34,316,000 | -33,105,000 | -51,655,000 | -31,165,000 | -19,491,000 | -26,662,000 | -56,233,000 | -26,943,000 | -20,724,000 | -22,512,000 | -34,398,000 | -28,695,000 | -18,556,000 | -19,381,000 | -45,362,000 | -37,576,000 | -26,408,000 | -33,836,000 |
free cash flows | 32,000,000 | 146,000,000 | -52,000,000 | 208,000,000 | 263,000,000 | 155,000,000 | -19,000,000 | 531,000,000 | 320,000,000 | 133,000,000 | -48,000,000 | 48,000,000 | 181,000,000 | -200,000,000 | -136,000,000 | 160,000,000 | 351,000,000 | 268,000,000 | 265,000,000 | 231,346,000 | 162,595,000 | 159,712,000 | -31,349,000 | 240,401,000 | 156,764,000 | 76,199,000 | -10,377,000 | 167,944,000 | 111,789,000 | 32,248,000 | -44,500,000 | 139,612,000 | 110,403,000 | 16,729,000 | -4,961,000 | 149,820,000 | 147,860,000 | 102,211,000 | 9,103,000 | 104,485,000 | 99,682,000 | 116,286,000 | 12,095,000 | 155,525,000 | 125,897,000 | 92,629,000 | 1,157,000 |
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||
additions to property, plant and equipment | -132,000,000 | -95,000,000 | -179,000,000 | -160,000,000 | -103,000,000 | -82,000,000 | -118,000,000 | -113,000,000 | -100,000,000 | -115,000,000 | -175,000,000 | -160,000,000 | -108,000,000 | -104,000,000 | -132,000,000 | -151,000,000 | -77,000,000 | -72,000,000 | -93,000,000 | -67,724,000 | -44,037,000 | -31,739,000 | -48,294,000 | -75,529,000 | -41,355,000 | -61,485,000 | -57,609,000 | -67,673,000 | -35,000,000 | -34,316,000 | -33,105,000 | -51,655,000 | -31,165,000 | -19,491,000 | -26,662,000 | -56,233,000 | -26,943,000 | -20,724,000 | -22,512,000 | -34,398,000 | -28,695,000 | -18,556,000 | -19,381,000 | -45,362,000 | -37,576,000 | -26,408,000 | -33,836,000 |
additions to intangible assets | 0 | 0 | 0 | 0 | -2,000,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||
proceeds from disposal of assets | 13,000,000 | 3,000,000 | 5,000,000 | 1,000,000 | 14,000,000 | 7,000,000 | 7,000,000 | -3,000,000 | 2,000,000 | 2,000,000 | 5,000,000 | 11,000,000 | 1,000,000 | 1,000,000 | -1,013,000 | 17,510,000 | -3,114,000 | 3,806,000 | 7,505,000 | 9,922,000 | 20,715,000 | 3,970,000 | 7,215,000 | 343,000 | 325,000 | 293,000 | 14,864,000 | 802,000 | -146,000 | 619,000 | 3,192,000 | 34,000 | 2,264,000 | 1,366,000 | 871,000 | 1,916,000 | 65,000 | 1,450,000 | 789,000 | 432,000 | 32,000 | 2,042,000 | |||||
net proceeds received from business disposals | 0 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash received on foreign currency forward contracts | 19,000,000 | 90,000,000 | 22,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
joint venture capital contributions | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -115,000,000 | 2,698,000,000 | -157,000,000 | -260,000,000 | -78,000,000 | 742,000,000 | -78,000,000 | -64,000,000 | 86,000,000 | 719,000,000 | -167,000,000 | -142,000,000 | 1,233,000,000 | -225,000,000 | -121,000,000 | -93,000,000 | 45,000,000 | -85,000,000 | 115,000,000 | -68,737,000 | -41,124,000 | -34,853,000 | -42,749,000 | -68,024,000 | -11,604,000 | -55,939,000 | -90,299,000 | -4,910,948,000 | -32,820,000 | -34,228,000 | -35,239,000 | -36,750,000 | -31,153,000 | -69,839,000 | -162,188,000 | -289,228,000 | -25,988,000 | -19,101,000 | -21,146,000 | -31,089,000 | -331,093,000 | -197,043,000 | -17,931,000 | -40,797,000 | -37,144,000 | -21,034,000 | -122,358,000 |
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||
cash dividends paid to shareholders | -102,000,000 | -102,000,000 | -102,000,000 | -103,000,000 | -102,000,000 | -102,000,000 | -207,000,000 | -207,000,000 | -206,000,000 | -207,000,000 | -206,000,000 | -206,000,000 | -202,000,000 | -201,000,000 | -201,000,000 | -201,000,000 | -192,000,000 | -192,000,000 | -82,000,000 | -82,311,000 | -80,173,000 | -80,062,000 | -80,038,000 | -80,033,000 | -77,899,000 | -77,799,000 | -77,779,000 | -66,900,000 | -54,494,000 | -54,404,000 | -54,420,000 | -54,440,000 | -50,494,000 | -50,507,000 | -50,677,000 | -50,846,000 | -44,588,000 | -44,637,000 | -44,826,000 | -44,995,000 | -37,948,000 | -37,956,000 | -37,971,000 | -38,126,000 | -31,696,000 | -31,674,000 | -31,743,000 |
net borrowings of commercial paper | 292,000,000 | -644,000,000 | 833,000,000 | 393,000,000 | 305,000,000 | 227,000,000 | |||||||||||||||||||||||||||||||||||||||||
principal payments of debt | -500,000,000 | -2,397,000,000 | -16,000,000 | -56,000,000 | -125,000,000 | ||||||||||||||||||||||||||||||||||||||||||
deferred and contingent consideration paid | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
withholding tax paid on stock-based compensation | -1,000,000 | -1,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
other | -4,000,000 | -10,000,000 | -5,000,000 | -2,000,000 | -4,000,000 | -2,000,000 | -2,000,000 | 1,000,000 | -3,000,000 | -5,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||
net cash from financing activities | -237,000,000 | -2,823,000,000 | 169,000,000 | -162,000,000 | -421,000,000 | -1,063,000,000 | 40,000,000 | -558,000,000 | -427,000,000 | -944,000,000 | 78,000,000 | -142,000,000 | -1,464,000,000 | 282,000,000 | 95,000,000 | -282,000,000 | -595,000,000 | -212,000,000 | -215,000,000 | -93,561,000 | -203,420,000 | -107,361,000 | -107,228,000 | -139,249,000 | -131,375,000 | -122,254,000 | -112,179,000 | 49,608,000 | 4,845,632,000 | -9,922,000 | -14,615,000 | -100,054,000 | -286,115,000 | 229,884,000 | 113,727,000 | -85,469,000 | -187,350,000 | -86,154,000 | 339,279,000 | -198,174,000 | 113,845,000 | -7,425,000 | -39,542,000 | -74,208,000 | -38,497,000 | -40,297,000 | -49,328,000 |
effect of exchange rate changes on cash and cash equivalents | -7,000,000 | 3,853,000 | -214,000 | -7,565,000 | -5,267,000 | -1,521,000 | -2,419,000 | 316,000 | -4,946,000 | 2,835,000 | -6,094,000 | -2,727,000 | -6,565,000 | -2,859,000 | 92,000 | -16,107,000 | 3,191,000 | -8,887,000 | -12,145,000 | -9,849,000 | 563,000 | -228,000 | |||||||||||||||||||||||||
net change in cash and cash equivalents and restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents and restricted cash at beginning of year | |||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of period | -195,000,000 | 497,129,000 | 4,952,036,000 | 17,147,000 | 305,276,000 | -175,384,000 | 191,319,000 | 300,067,000 | -41,262,000 | 11,115,000 | 528,877,000 | -104,978,000 | -66,435,000 | 443,689,000 | 77,983,000 | 58,269,000 | 268,584,000 | ||||||||||||||||||||||||||||||
supplemental disclosures: | |||||||||||||||||||||||||||||||||||||||||||||||
interest paid, net of amounts capitalized | 45,000,000 | 93,000,000 | 37,000,000 | 92,000,000 | 58,000,000 | 97,000,000 | 61,000,000 | 109,000,000 | 70,000,000 | 125,000,000 | 66,000,000 | 111,000,000 | 56,000,000 | 98,000,000 | 45,000,000 | 94,000,000 | 56,000,000 | 118,000,000 | 42,000,000 | 14,900,000 | 55,542,000 | 15,356,000 | 41,755,000 | 21,973,000 | 48,506,000 | 17,452,000 | 54,186,000 | 20,236,000 | 16,817,000 | 5,150,000 | 16,667,000 | 20,037,000 | 4,242,000 | 20,729,000 | 19,044,000 | 4,130,000 | 19,697,000 | 2,698,000 | 3,676,000 | 20,033,000 | |||||||
income taxes paid | 123,000,000 | 53,000,000 | 86,000,000 | 122,000,000 | 63,000,000 | 132,000,000 | 53,000,000 | 128,000,000 | 46,000,000 | 177,000,000 | 227,000,000 | 53,000,000 | 49,000,000 | 149,000,000 | 78,000,000 | 91,000,000 | 64,000,000 | 98,000,000 | 36,000,000 | 31,482,000 | 43,446,000 | 25,225,000 | 32,636,000 | 40,585,000 | 33,326,000 | 28,863,000 | 32,870,000 | 24,939,000 | 26,394,000 | 30,919,000 | 20,043,000 | 27,331,000 | 28,835,000 | 23,884,000 | 25,096,000 | 25,437,000 | 20,634,000 | 17,523,000 | 26,803,000 | 18,681,000 | |||||||
accrued capital expenditures | 23,000,000 | 11,000,000 | 58,000,000 | 84,000,000 | 10,000,000 | 11,000,000 | 53,000,000 | 42,000,000 | 10,000,000 | -14,000,000 | 71,000,000 | 57,000,000 | 22,000,000 | 7,000,000 | 64,000,000 | 73,000,000 | 8,000,000 | 15,000,000 | 21,000,000 | 18,085,000 | -6,492,000 | 10,002,000 | 19,013,000 | 4,539,000 | 14,241,000 | 15,597,000 | -913,000 | 292,000 | 18,868,000 | ||||||||||||||||||
net change in cash and cash equivalents | -151,393,000 | 4,952,036,000 | 17,147,000 | -62,770,000 | 52,044,000 | -175,384,000 | 191,319,000 | -23,925,000 | -174,738,000 | -41,262,000 | 11,115,000 | 346,889,000 | -90,288,000 | -104,978,000 | -66,435,000 | -34,884,000 | 73,737,000 | 77,983,000 | 58,269,000 | -136,921,000 | |||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | 648,522,000 | 0 | 0 | 368,046,000 | 0 | 0 | 0 | 323,992,000 | 0 | 0 | 0 | 181,988,000 | 0 | 0 | 0 | 478,573,000 | 0 | 0 | 0 | 405,505,000 | |||||||||||||||||||||||||||
gains on sales of assets | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of assets | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
increase in revolving credit facility and short-term borrowings | 250,000,000 | 0 | 0 | -100,000,000 | -349,000,000 | 350,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | 40,000,000 | -44,000,000 | 28,000,000 | -13,000,000 | -25,000,000 | 51,000,000 | -69,000,000 | 12,000,000 | 27,000,000 | 73,000,000 | -76,000,000 | -50,000,000 | -24,000,000 | -15,000,000 | -26,000,000 | 19,000,000 | -37,000,000 | 39,574,000 | 9,504,000 | 14,313,000 | -42,529,000 | -5,906,000 | |||||||||||||||||||||||||
net change in cash, cash equivalents and restricted cash | 179,000,000 | -98,000,000 | -105,000,000 | -97,000,000 | 36,000,000 | 73,000,000 | 10,000,000 | 35,000,000 | 65,000,000 | -3,000,000 | -18,000,000 | -89,000,000 | -54,000,000 | -79,000,000 | -148,000,000 | 62,000,000 | 221,000,000 | 176,346,000 | -28,408,000 | 63,550,000 | -175,561,000 | ||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of year | 471,000,000 | 0 | 0 | 0 | 735,000,000 | 0 | 0 | 0 | 552,000,000 | 0 | 0 | 0 | 716,000,000 | 0 | 0 | 0 | 660,000,000 | 0 | 0 | 0 | 623,945,000 | ||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | 650,000,000 | -105,000,000 | -97,000,000 | 771,000,000 | 10,000,000 | 35,000,000 | 617,000,000 | -18,000,000 | -89,000,000 | 662,000,000 | -148,000,000 | 62,000,000 | 881,000,000 | -28,408,000 | 63,550,000 | 448,384,000 | |||||||||||||||||||||||||||||||
adjustments to reconcile to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||
gains on sale of assets | 0 | -1,000,000 | -8,000,000 | -2,000,000 | -2,000,000 | 1,000,000 | -188,000 | -742,000 | |||||||||||||||||||||||||||||||||||||||
(gains) losses on business disposals | 2,000,000 | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
pension-related expense | |||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
inventory write-down | 10,000,000 | 18,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisitions, net of cash received | 0 | 13,000,000 | 0 | -1,000 | -15,169,000 | -33,895,000 | -4,857,321,000 | 0 | 0 | -22,000 | -1,024,000 | 0 | -53,211,000 | -138,093,000 | 45,000 | ||||||||||||||||||||||||||||||||
proceeds from unwinding of derivative instruments | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
cash from the merger with n&b | 0 | 0 | 0 | 11,000,000 | 53,000,000 | 0 | -14,000,000 | 207,000,000 | |||||||||||||||||||||||||||||||||||||||
cash paid on foreign currency forward contracts | |||||||||||||||||||||||||||||||||||||||||||||||
dividends paid to redeemable non-controlling interests | |||||||||||||||||||||||||||||||||||||||||||||||
increase in revolving credit facility and short term borrowings | 468,000 | -1,292,000 | 169,000 | 3,000 | -2,887,000 | 2,895,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of commercial paper | 65,000,000 | 0 | 5,000,000 | 155,000,000 | 124,000,000 | ||||||||||||||||||||||||||||||||||||||||||
repayments of commercial paper | -186,000,000 | -5,000,000 | -155,000,000 | -75,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of redeemable non-controlling interests | |||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of year | |||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||
other current payables and accrued expenses | 143,000,000 | -50,000,000 | -28,000,000 | 235,000,000 | 32,000,000 | -197,000,000 | -51,000,000 | -110,000,000 | 269,000,000 | -106,000,000 | 39,000,000 | -95,000,000 | 67,000,000 | -16,000,000 | 48,000,000 | -2,621,000 | 89,957,000 | 35,163,000 | -65,158,000 | 17,649,000 | -227,000 | -613,000 | -11,321,000 | -5,665,000 | -10,642,000 | 29,568,000 | -18,540,000 | 13,256,000 | 12,522,000 | 4,187,000 | -7,286,000 | 18,440,000 | 11,863,000 | 8,344,000 | 10,456,000 | -5,461,000 | 14,381,000 | -60,000 | 20,264,000 | -23,486,000 | 16,536,000 | -13,478,000 | 1,096,000 | ||||
decrease in revolving credit facility and short-term borrowings | -1,000,000 | 0 | -104,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
net proceeds received from business divestitures | 811,000,000 | 37,000,000 | 44,000,000 | 185,000,000 | |||||||||||||||||||||||||||||||||||||||||||
losses on business divestitures | 5,000,000 | 14,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
deferred financing costs | 0 | -3,000,000 | 0 | -2,000,000 | 0 | -11,724,000 | -20,543,000 | 0 | 0 | -1,008,000 | 16,000 | 0 | -4,796,000 | 0 | 0 | ||||||||||||||||||||||||||||||||
repayments of long-term debt | -833,000,000 | -300,000,000 | -55,000,000 | 0 | -200,000,000 | ||||||||||||||||||||||||||||||||||||||||||
employee withholding taxes paid | -1,000,000 | -1,000,000 | -1,000,000 | -5,000,000 | -6,000,000 | -1,000,000 | 0 | -7,000,000 | -13,000,000 | -1,000,000 | -1,000,000 | -13,000,000 | -6,000,000 | -437,000 | -70,000 | -6,319,000 | -1,275,000 | -821,000 | -111,000 | -8,516,000 | -1,339,000 | 0 | -629,000 | -5,830,000 | -3,266,000 | -259,000 | -24,000 | -8,485,000 | -3,000,000 | ||||||||||||||||||
losses (gains) on business divestitures | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
amortization of inventory step-up | 5,000,000 | -14,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | 0 | 0 | 0 | 330,328,000 | 0 | 0 | 0 | 0 | 0 | 555,559,000 | |||||||||||||||||||||||||||||||||||||
deferred consideration paid | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
net repayments of commercial paper | |||||||||||||||||||||||||||||||||||||||||||||||
gains on sale of fixed assets | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net proceeds received from business divestiture | 1,000,000 | 11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
(gains) losses on sale of fixed assets | |||||||||||||||||||||||||||||||||||||||||||||||
gains on business divestiture | |||||||||||||||||||||||||||||||||||||||||||||||
maturity of net investment hedges | 0 | 0 | 0 | -237,000 | -2,405,000 | -792,000 | -790,000 | 1,068,000 | 1,948,000 | 649,000 | 629,000 | 2,393,000 | 0 | 3,776,000 | 0 | 0 | -472,000 | ||||||||||||||||||||||||||||||
proceeds from life insurance contracts | 0 | 0 | 0 | 1,739,000 | 0 | 0 | 0 | 1,890,000 | 0 | 1,857,000 | 0 | 0 | 0 | 320,000 | 0 | 0 | |||||||||||||||||||||||||||||||
dividends paid to redeemable non-controlling interest | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of redeemable non-controlling interest | |||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration paid | 0 | 0 | -14,000,000 | 0 | 0 | 0 | -4,655,000 | ||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock in connection with stock options | 0 | 0 | 7,000,000 | 1,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 0 | 0 | 200,000 | |||||||||||||||||||||||||||||||||||||
gains on sales of fixed assets | |||||||||||||||||||||||||||||||||||||||||||||||
gain on business divestiture | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of redeemable noncontrolling interest | -24,000,000 | 0 | 0 | -7,393,000 | -14,173,000 | ||||||||||||||||||||||||||||||||||||||||||
purchases of noncontrolling interest | 0 | 0 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
(gains) losses on sale of assets | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from unwinding of cross currency swap derivative instruments | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds received from sale of business | |||||||||||||||||||||||||||||||||||||||||||||||
dividends paid to redeemable noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||||
decrease in revolving credit facility and short term borrowing | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds received in advance of sale of business | |||||||||||||||||||||||||||||||||||||||||||||||
losses on sale of assets | 415,000 | ||||||||||||||||||||||||||||||||||||||||||||||
repayments on debt | -12,000,000 | -12,000,000 | -311,805,000 | -11,695,000 | -11,584,000 | -53,368,000 | -11,261,000 | -36,156,000 | |||||||||||||||||||||||||||||||||||||||
other assets | 229,000,000 | 87,595,000 | -64,926,000 | -50,422,000 | 42,462,000 | -8,634,000 | -28,027,000 | -20,011,000 | -9,978,000 | 42,378,000 | 4,023,000 | -39,585,000 | -26,035,000 | -7,690,000 | -14,183,000 | -11,009,000 | 29,016,000 | 7,713,000 | -8,809,000 | -8,385,000 | -1,569,000 | 4,446,000 | |||||||||||||||||||||||||
other liabilities | -208,000,000 | -34,647,000 | 4,005,000 | -7,165,000 | 10,467,000 | -36,791,000 | -7,481,000 | 43,306,000 | -6,894,000 | 4,232,000 | -1,364,000 | 10,366,000 | -1,715,000 | 60,201,000 | -4,857,000 | -14,566,000 | -20,720,000 | 10,169,000 | 18,004,000 | 14,703,000 | 4,691,000 | 4,215,000 | |||||||||||||||||||||||||
loss on extinguishment of debt | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
gain on deal contingent derivatives | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposal of subsidiaries, net of cash held | |||||||||||||||||||||||||||||||||||||||||||||||
repayments of debt | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of equity securities, net of issuance costs | -871,000 | ||||||||||||||||||||||||||||||||||||||||||||||
gain on pre-issuance hedges | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury stock | 0 | 0 | -4,858,000 | -10,617,000 | -4,858,000 | 0 | -15,599,000 | -37,612,000 | -33,295,000 | -22,434,000 | -31,707,000 | -40,007,000 | -40,956,000 | -42,424,000 | -28,153,000 | -10,660,000 | -35,750,000 | -18,350,000 | -13,981,000 | -20,122,000 | |||||||||||||||||||||||||||
litigation settlement | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
foreign currency gain on liquidation of entity | -3,000 | 0 | 0 | -12,214,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock in connection with stock plans | |||||||||||||||||||||||||||||||||||||||||||||||
cash paid for: | |||||||||||||||||||||||||||||||||||||||||||||||
interest, net of amounts capitalized | |||||||||||||||||||||||||||||||||||||||||||||||
income taxes | |||||||||||||||||||||||||||||||||||||||||||||||
noncash investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||
product recall claim settlement, net of insurance proceeds received | 3,325,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from pre-issuance hedges | |||||||||||||||||||||||||||||||||||||||||||||||
treasury stock issued in the frutarom acquisition | |||||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of assets | 1,264,000 | -69,000 | -64,000 | -31,000 | -68,000 | -21,000 | -7,838,000 | -281,000 | -355,000 | -1,417,000 | -782,000 | -758,000 | -811,000 | ||||||||||||||||||||||||||||||||||
product recall claim settlement | 0 | -12,969,000 | |||||||||||||||||||||||||||||||||||||||||||||
increase in revolving credit facility borrowings and overdrafts | 86,497,000 | 23,762,000 | -75,680,000 | 97,275,000 | -657,000 | ||||||||||||||||||||||||||||||||||||||||||
loss on pre-issuance hedges | 0 | 0 | -5,610,000 | 300,000 | 0 | 0 | 0 | -3,244,000 | |||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock under stock plans | 0 | 0 | 219,000 | 100,000 | 331,000 | 163,000 | 598,000 | 2,000 | 59,000 | 227,000 | 503,000 | 337,000 | 111,000 | 913,000 | |||||||||||||||||||||||||||||||||
increase in commercial paper | 29,926,000 | 107,441,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||||||||||||||||||||||||||||||
decrease in revolving credit facility borrowings and overdrafts | |||||||||||||||||||||||||||||||||||||||||||||||
excess tax benefits on stock-based payments | 118,000 | 101,000 | 3,399,000 | 1,032,000 | 351,000 | 96,000 | 3,011,000 | 8,597,000 | 250,000 | 292,000 | 5,473,000 | 315,000 | |||||||||||||||||||||||||||||||||||
(gain) loss on disposal of assets | -197,000 | -2,713,000 | 34,000 | ||||||||||||||||||||||||||||||||||||||||||||
net change in revolving credit facility borrowings and overdrafts | -13,540,000 | -124,602,000 | -548,000 | 265,000 | -594,000 | 6,820,000 | 797,000 | 1,309,000 | |||||||||||||||||||||||||||||||||||||||
proceeds from issuance or drawdown of long-term debt | 193,836,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net change in bank borrowings and overdrafts | |||||||||||||||||||||||||||||||||||||||||||||||
cash paid for acquisition, net of cash received | 0 | 0 | -100,000 | -102,400,000 | |||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of aromor acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
spanish tax charges | |||||||||||||||||||||||||||||||||||||||||||||||
payments pursuant to spanish tax settlement | |||||||||||||||||||||||||||||||||||||||||||||||
changes in other assets/liabilities | |||||||||||||||||||||||||||||||||||||||||||||||
purchase of life insurance contracts | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long-term debt | -491,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from termination of life insurance contracts | 12,308,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
